We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Reports Only Mild-to-Moderate Side Effects of COVID-19 Vaccine in Late-Stage Trial
Pfizer Reports Only Mild-to-Moderate Side Effects of COVID-19 Vaccine in Late-Stage Trial
Pfizer reported early safety data yesterday from its phase 3 COVID-19 vaccine trial, saying the vaccine prompted mostly mild to moderate adverse reactions in patients.